OKYO Pharma Limited

OKYO Pharma Limited financial statements

OKYO Pharma Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 0EODHD
Net income−USD 8.95MEODHD
Cash and equivalentsUSD 14.59MEODHD

OKYO Pharma Limited financials on 6ix · OKYO Pharma Limited on 6ix